ResQ Pharma, Inc
ResQ Pharma, Inc
  • Home
  • About Us
  • Background
  • Target Indications
  • History
  • Contact
  • More
    • Home
    • About Us
    • Background
    • Target Indications
    • History
    • Contact
  • Home
  • About Us
  • Background
  • Target Indications
  • History
  • Contact

LIPIDRESCUE® TIMELINE

NOTE:

   LipidRescue® is an investigational drug; the safety and efficacy of the drug have not been approved or authorized by FDA.  LipidRescue® is a proposed proprietary name that is subject to FDA approval. 

SINCE 2006

The medical literature suggests that LipidRescue® has contributed to saving countless lives. Dozens of published peer-reviewed reports support its potential efficacy and safety in treating LAST and potentially contributing to survival from various types of NODO.

1998

Dr. Guy Weinberg discovered that LipidRescue® Therapy (infusing a lipid emulsion) rapidly reverses severe LAST in rats and dogs.

2006

The journal Anesthesiology published the first case report of LipidRescue® Therapy saving a patient with LAST.

2008

Annals of Emergency Medicine published the first report of LipidRescue® Therapy in non-opiate drug overdose.

2010

Advisories published by the American Society of Regional Anesthesia and Pain Medicine and the Association of Anesthetists of Great Britain and Ireland established LipidRescue® Therapy as first-line treatment for LAST. 

2015

The American Heart Association recommended  LipidRescue® Therapy in LAST and other, specific types of drug overdose including certain types of NODO. 

WHAT'S NEXT?

ResQ Pharma received Orphan Drug designation from the FDA for use of  LipidRescue® Therapy in the treatment of LAST. ResQ anticipates filing an NDA for a kit to treat LAST in 2022

  

LipidRescue® is an investigational drug; the safety and efficacy of the drug have not been approved or authorized by FDA. 

LipidRescue® is a proposed proprietary name that is subject to FDA approval. 


Website designed by JDW

Copyright © 2021 ResQ Pharma, Inc - All Rights Reserved.


Powered by GoDaddy